Welcome to our dedicated page for Davita news (Ticker: DVA), a resource for investors and traders seeking the latest updates and insights on Davita stock.
DaVita Inc. provides comprehensive kidney care through a global dialysis and care-delivery network. Company news commonly covers quarterly operating results, revenue per treatment, patient care costs, reimbursement trends, share repurchases and investor conference participation.
Updates also address DaVita's value-based kidney care programs, coordinated care arrangements, and services that support patients across stages and settings of kidney disease, including home support, outpatient dialysis centers, hospitals, skilled nursing facilities and transplantation-related care.
DaVita Inc. (NYSE: DVA) has announced a private offering of $1.5 billion in senior notes due 2031, subject to market conditions. The proceeds will be used to redeem all outstanding 5.000% senior notes due 2025, totaling $1.5 billion. A notice of redemption for the 2025 notes will be issued, contingent on the completion of the new offering. The notes are being offered under Rule 144A and Regulation S of the Securities Act. Risks include market conditions affecting the offering and ongoing impacts from the COVID-19 pandemic.
During Q2 2020, DaVita (NYSE: DVA) reported consolidated revenues of $2.880 billion with an operating income of $410 million, achieving a 14.2% operating margin. The company focused on patient care amid the COVID-19 pandemic, enhancing safety through testing and telehealth. Diluted EPS from continuing operations was $1.62, up from $1.16 Y-o-Y. Operating cash flow reached $651 million. DaVita treats over 236,000 patients at around 3,082 centers. However, the company reported a $16 million loss on the sale of its vascular access business.
DaVita Inc. (NYSE: DVA) has announced a quarterly conference call scheduled for July 30, 2020, at 5:00 p.m. Eastern Time to discuss its second-quarter results. Results will be released after market close on the same day. Investors can access the call via phone at 877-918-6630 (international 517-308-9042) or through a webcast on the DaVita IR web page. The company is a leading provider of kidney care services, treating 207,000 patients across 2,772 outpatient centers in the U.S. as of March 31, 2020.
DaVita Kidney Care announced the appointment of Mandy Hale as the new chief nursing officer, effective immediately. Hale previously served as vice president of nursing, managing over 18,000 nurses. With a career spanning over two decades at DaVita, she has held various leadership roles, enhancing nursing strategy and patient care. Hale's educational qualifications include a Master of Science in nursing, an MBA, and a doctorate of nursing practice. CEO Javier Rodriguez praised her leadership qualities, anticipating a positive impact on patient care.